PharmaCom BioVet, Inc.
PharmaCom BioVet, Inc.
- Market cap
- $1.08M
Your view on PHMB
Overview
What the company does, where it operates, and who runs it.
About PharmaCom BioVet, Inc.
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Ira Frohman
- Headquarters
- 6040-A Six Forks Road, Raleigh, NC, US
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Ira Frohman
- Headquarters
- 6040-A Six Forks Road, Raleigh, NC, US
PharmaCom BioVet, Inc. focuses on operating a network of companion animal cancer treatment centers in the United States.
The company focuses on developing bone marrow transplantation and other cancer treatment procedures to benefit companion animals that are diagnosed with lymphoma, other different types of cancers, and other diseases that are incurable. It has licensed a series of proprietary devices and compounds that would reduce suffering in animals with cancer.
The company was formerly known as ABV Gold Inc. and changed its name to PharmaCom BioVet, Inc. in August 2008. PharmaCom BioVet, Inc. was incorporated in 1995 and is headquartered in Raleigh, North Carolina.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for PharmaCom BioVet, Inc.. Starting points for PharmaCom BioVet, Inc.: beta -6.74 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for PharmaCom BioVet, Inc.. PharmaCom BioVet, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for PharmaCom BioVet, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for PharmaCom BioVet, Inc.. PharmaCom BioVet, Inc. has reported as a listed company since 1999. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CYHCommunity Health Systems, Inc. | Healthcare | NYSE | $228.5M | ||
| CYIOCYIOS Corporation | Healthcare | OTC | $43,629 | ||
| DCGODocGo Inc. | Healthcare | NASDAQ | $17.3M | ||
| DPATDental Patient Care America, Inc. | Healthcare | OTC | $1.2M | ||
| DR.TOMedical Facilities Corporation | Healthcare | TSX | $283.6M | ||
| DRWNQuantum Medical Transport, Inc. | Healthcare | OTC | $23,978 | ||
| DVADaVita Inc. | Healthcare | NYSE | $10.1B | ||
| EHCEncompass Health Corporation | Healthcare | NYSE | $13.1B | ||
| ENSGThe Ensign Group, Inc. | Healthcare | NASDAQ | $10.3B | ||
| ERUCER Urgent Care Holdings, Inc. | Healthcare | OTC | $3,915 | ||
| ETAOFETAO International Co., Ltd. | Healthcare | OTC | $2,049 | ||
| EUDAEUDA Health Holdings Limited | Healthcare | NASDAQ | $47.8M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for PharmaCom BioVet, Inc.. Coverage tracks PharmaCom BioVet, Inc. within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of PharmaCom BioVet, Inc.